ESKAPE and Beyond: The Burden of Coinfections in the COVID-19 Pandemic

Pathogens. 2023 May 22;12(5):743. doi: 10.3390/pathogens12050743.

Abstract

The ESKAPE group constitute a threat to public health, since these microorganisms are associated with severe infections in hospitals and have a direct relationship with high mortality rates. The presence of these bacteria in hospitals had a direct impact on the incidence of healthcare-associated coinfections in the SARS-CoV-2 pandemic. In recent years, these pathogens have shown resistance to multiple antibiotic families. The presence of high-risk clones within this group of bacteria contributes to the spread of resistance mechanisms worldwide. In the pandemic, these pathogens were implicated in coinfections in severely ill COVID-19 patients. The aim of this review is to describe the main microorganisms of the ESKAPE group involved in coinfections in COVID-19 patients, addressing mainly antimicrobial resistance mechanisms, epidemiology, and high-risk clones.

Keywords: COVID-19; ESKAPE; SARS-CoV-2; antimicrobial resistance.

Publication types

  • Review

Grants and funding

This research received no external funding.